annexonbio.com (ANNX) - Uzoq muddatli majburiyatlarning kapitalga nisbati
Annexon, Inc. (ANNX) kompaniyasining kunlik narxlar dinamikasi maqsadli neyrodegeneratsiya davolash vositalarini ishlab chiquvchi ushbu korxonaning yuqori nufuzini aks ettiradi, uning tan olinishi esa muvaffaqiyatli sinovlar bilan tasdiqlangan. Ko'rsatkich 0.12 darajasida turibdi, shu bilan birga sezilarli miqdordagi kapital tadqiqot va ishlanmalar (R&D) jarayonlarini tebranishlardan himoya qiladi. O'sish istiqbollari ko'z atrofiya va Giyyen-Barre sindromiga qarshi kurashishning innovatsion usuliga asoslangan bo'lib, bu sanoatning yirik ishtirokchisi tomonidan sotib olinish ehtimolini oshiradi.
&width=1200&height=400&colorIndex=0&v=mvt4kixj.9g-7avve2o&start=20220704&end=20261029&filename=GURU_Markets_-_ANNX_-_Annexon-Inc._-_Long-Term-Debt-to-Equity-Ratio "ANNX - Annexon Uzoq muddatli qarzning kapitalga nisbati 04.07.2022 - 29.10.2026 oraligʻida | 👁️GURU.Markets👁️")
Annexon, Inc. (ANNX) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil
- joriy narx va aksiyalarning prognoz qilingan qiymati:
- bozor kapitallashuvi ko'rsatkichlari:
- xususiy kapitalning balans qiymati ko'rsatkichlari:
- qarz majburiyatlari va likvidlik statistikasi:
Qarzning kapitalga nisbati Annexon, Inc.|ANNX - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning kapitalga nisbati annexonbio.com|ANNX - Kompaniya qarzlari|Qarzning balans qiymatiga nisbati Annexon Biosciences|ANNX - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli qarzdorligi Annexon|Shoshilinch likvidlik annexonbio.com
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
Kompaniyaning har tomonlama tahlili:Annexon Biosciences ANNX
Nevrologiya va oftalmologiya sohalaridagi autoimmun patologiyalar uchun dori vositalarini ishlab chiquvchi Annexon, Inc. (ANNX) uchun uzoq muddatli majburiyatlar balansi kengaytirilgan R&D sikllarini moliyalashtirishda hal qiluvchi ahamiyatga ega. Ushbu ko'rsatkich bir yildan ortiq muddatga ega bo'lgan kreditlarni kapital bilan solishtiradi, bu esa kompaniyaning uzoq muddatli moliyaviy bog'liqlikning joriy darajasi va potensial defolt xavfi orqali foiz stavkalari shoklariga chidamliligini baholash imkonini beradi.
Raqobatdosh kompaniyalar tahlili
Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi BIIB (Biogen Inc)|Uzoq muddatli qarzning kapitalga nisbati NBIX|RGC - Uzoq muddatli majburiyatlarning kapitalga nisbati|Axsome Therapeutics - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati acadia-pharm.com ACAD|XENE - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti VKTX (Viking Therapeutics Inc)|Supernus Pharma (SUPN) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Catalyst Corp (CPRX)|DNLI (Denali Therapeutics) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati harmonybiosciences.com|Uzoq muddatli qarzning o'z kapitaliga nisbati Biohaven (BHVN)|Amylyx Pharmaceuticals Inc - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning o'z kapitaliga nisbati Trevi Pharma TRVI|PRAX: Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Anavex Life Sciences - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati ceribell.com|PRTA (Prothena Corp) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi ALEC|Uzoq muddatli qarzning o'z kapitaliga nisbati Omeros Corp|Uzoq muddatli majburiyatlarning kapitalga nisbati Neurogene Therapeutics NGNE|Uzoq muddatli qarzning o'z kapitaliga nisbati AC Immune (ACIU)|voyagertherapeutics.com - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Neumora Therapeutics, Inc. - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti SCLX|Tevogen Bio Holdings, Inc. - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati Alpha Cognition ACOG|Cognition Therapeutics (CGTX) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi IKT|SAVA (Cassava Sciences) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Assertio Therapeutics (ASRT)|Uzoq muddatli qarzning o'z kapitaliga nisbati COYA (Coya Therapeutics, Inc.)|Uzoq muddatli qarzdorlikning kapitalga nisbati vistagen.com|Uzoq muddatli qarzning kapitalga nisbati OVID (Ovid Therapeutics)|Uzoq muddatli qarzning kapitalga nisbati acumenpharm.com ABOS|CRVO - Uzoq muddatli qarzning o'z kapitaliga nisbati|ATHE (Alterity Therapeutics) - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|clene.com (CLNN) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi PEPG|Uzoq muddatli qarzning o'z kapitaliga nisbati JUNS|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi RLMD (relmada.com)|Uzoq muddatli qarzning o'z kapitaliga nisbati Annovis Bio (ANVS)|gracetx.com - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning kapitalga nisbati AIFF (Firefly Neuroscience Inc)|ANEW Medical (KLTO) - Uzoq muddatli majburiyatlarning kapitalga nisbati|NRSN: Uzoq muddatli qarzning o'z kapitaliga nisbati|RVPH - Uzoq muddatli qarzning kapitalga nisbati|metaviatx.com (MTVA) - Uzoq muddatli qarzning o'z kapitaliga nisbati|NeurAxis Inc. - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati Helius Medical Technologies, Inc.|Uzoq muddatli majburiyatlarning kapitalga nisbati Passage Bio Corp PASG|Uzoq muddatli qarzning kapitalga nisbati NEUP|Uzoq muddatli qarzning kapitalga nisbati minervaneurosciences.com (NERV)|Uzoq muddatli qarzning o'z kapitaliga nisbati Athira Pharma ATHA|ADXN: Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|ALZN - Uzoq muddatli qarzning o'z kapitaliga nisbati|CYCN (Cyclerion Therapeutics) - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|PTIX: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Pasithea Therapeutics Corp. (KTTA)|Uzoq muddatli qarzning o'z kapitaliga nisbati CRGT|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi ATXI (Avenue Therapeutics Inc.)|Uzoq muddatli qarzning o'z kapitaliga nisbati Brainstorm Cell Therapeutics, Inc. (BCLI)|CARA - Uzoq muddatli majburiyatlarning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Chromocell Therapeutics CHRO|ELYM: Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|ITCI: Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti LBPH (Longboard Pharmaceuticals Inc)|MRNS: Uzoq muddatli qarzning kapitalga nisbati|NKGN - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati NeuroBo Pharmaceuticals|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi SAGE (sagerx.com)|Uzoq muddatli qarzning kapitalga nisbati SNPX|Uzoq muddatli qarzning o'z kapitaliga nisbati Trevena Inc. TRVN|Vigil Neuroscience, Inc. - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati Anew Medical Inc. (WENA)|Cerevel Therapeutics - Uzoq muddatli qarzning kapitalga nisbati